A Comparison of Attitudes, Comfort, and Knowledge of Clozapine Among Two Diverse Samples of US Psychiatrists
| Autor: | A. Umair Janjua, Robert O. Cotes, David Lazris, David R. Goldsmith, Ayesha Khan, Yunshen Jiao, Sarah L Kopelovich, Beth Broussard |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Psychiatry
Polypharmacy medicine.medical_specialty Health (social science) Attitude of Health Personnel business.industry medicine.medical_treatment education Public Health Environmental and Occupational Health medicine.disease Article United States Psychiatry and Mental health Continuing professional development Schizophrenia medicine Humans business Antipsychotic Clozapine Antipsychotic Agents medicine.drug |
| Zdroj: | Community Ment Health J |
| ISSN: | 1573-2789 0010-3853 |
| DOI: | 10.1007/s10597-021-00847-0 |
| Popis: | Considerable variation in clozapine utilization exists across the United States, and little is known about the perspective of psychiatrists in states with low clozapine use. To better understand clozapine practices, attitudes, and barriers, a survey was administered to a group of southeastern state conference attendees (SSCA; N = 86). The same survey was administered to psychiatrists belonging to a national community psychiatry organization (AACP; N = 57), and differences were analyzed across the two samples. In comparison to the AACP, the SSCA group felt less comfortable, perceived clozapine as less safe and effective, had fewer patients on clozapine, and were more likely to prefer antipsychotic polypharmacy to clozapine use. Across the sample, use of a myocarditis screening protocol was rare (N = 14/76; 18%) and less than half used plasma antipsychotic levels to guide dosage (N = 60/129; 47%). Continuing professional education on clozapine are needed for psychiatrists who see individuals with psychotic disorders. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink